{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1361981468349080320.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1038/sj.npp.1300151"}},{"identifier":{"@type":"URI","@value":"http://www.nature.com/articles/1300151.pdf"}},{"identifier":{"@type":"URI","@value":"http://www.nature.com/articles/1300151"}},{"identifier":{"@type":"NAID","@value":"30010245133"}}],"dc:title":[{"@value":"The Muscarinic M1/M4 Receptor Agonist Xanomeline Exhibits Antipsychotic-Like Activity in Cebus apella Monkeys"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1381981468349080321","@type":"Researcher","foaf:name":[{"@value":"Maibritt B Andersen"}]},{"@id":"https://cir.nii.ac.jp/crid/1381981468349080320","@type":"Researcher","foaf:name":[{"@value":"Anders Fink-Jensen"}]},{"@id":"https://cir.nii.ac.jp/crid/1381981468349080322","@type":"Researcher","foaf:name":[{"@value":"Linda Peacock"}]},{"@id":"https://cir.nii.ac.jp/crid/1381981468349080323","@type":"Researcher","foaf:name":[{"@value":"Jes Gerlach"}]},{"@id":"https://cir.nii.ac.jp/crid/1381981468349080326","@type":"Researcher","foaf:name":[{"@value":"Frank Bymaster"}]},{"@id":"https://cir.nii.ac.jp/crid/1381981468349080324","@type":"Researcher","foaf:name":[{"@value":"Jens August Lundbæk"}]},{"@id":"https://cir.nii.ac.jp/crid/1381981468349080325","@type":"Researcher","foaf:name":[{"@value":"Thomas Werge"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"0893133X"},{"@type":"EISSN","@value":"1740634X"},{"@type":"PISSN","@value":"http://id.crossref.org/issn/0893133X"}],"prism:publicationName":[{"@value":"Neuropsychopharmacology"}],"dc:publisher":[{"@value":"Springer Science and Business Media LLC"}],"prism:publicationDate":"2003-01-08","prism:volume":"28","prism:number":"6","prism:startingPage":"1168","prism:endingPage":"1175"},"reviewed":"false","dc:rights":["http://www.springer.com/tdm"],"url":[{"@id":"http://www.nature.com/articles/1300151.pdf"},{"@id":"http://www.nature.com/articles/1300151"}],"createdAt":"2003-04-16","modifiedAt":"2023-05-16","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1390282679154644096","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Discovery and Development of Muscarinic Acetylcholine M<sub>4</sub> Activators as Promising Therapeutic Agents for CNS Diseases"},{"@value":"Discovery and Development of Muscarinic Acetylcholine M₄ Activators as Promising Therapeutic Agents for CNS Diseases"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282680153170304","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy","isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Effect of a Novel Potential Atypical Antipsychotic Drug, Y-931, in Producing Dystonia in Cebus Monkeys"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1038/sj.npp.1300151"},{"@type":"CIA","@value":"30010245133"},{"@type":"CROSSREF","@value":"10.1254/jphs.93.364_references_DOI_YZhBCmbGTu3hXmnBSvdchceo47w"},{"@type":"CROSSREF","@value":"10.1248/cpb.c17-00413_references_DOI_YZhBCmbGTu3hXmnBSvdchceo47w"}]}